Corticotropin-releasing factor: Began Phase I/II, open-label, dose-escalation trial in nine patients hospitalized with acute asthma. Following this trial, an ad

Neurobiological Technologies Inc. (NTII), Richmond, Calif. Product: Corticotropin-releasing factor, which blocks fluid leakage from lung vasculature Indication: Acute asthma Status: Began Phase I/II, ...